Insider · CIK 0001161662
Norbert G Riedel
director
Files at JAZZ (Jazz Pharmaceuticals plc), ETON (Eton Pharmaceuticals, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -14 | $244.64 | $3,425 | 8,615 | 40 d ago |
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -1,692 | $241.39 | $408k | 6,923 | 40 d ago |
| Aug 7, 2025 | JAZZ Jazz Pharmaceuticals plc | AGrant or award Ordinary Shares | +3,507 | $0.00 | $0 | 8,829 | Aug 11, 2025 |
| Aug 8, 2025 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -1,805 | $111.25 | $201k | 7,024 | Aug 11, 2025 |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jan 6, 2025 |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | MOption exercise Common Stock | +27,400 | $3.58 | $98k | 87,145 | Jan 6, 2025 |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | MOption exercise Common Stock | +50,000 | $3.78 | $189k | 137,145 | Jan 6, 2025 |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | MOption exercise Common Stock | +25,000 | $3.47 | $87k | 162,145 | Jan 6, 2025 |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -27,400 | $0.00 | $0 | 0 | Jan 6, 2025 |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -50,000 | $0.00 | $0 | 0 | Jan 6, 2025 |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.